Ferring has sense of humour when naming new anti-androgen.

"FDA has approved the trade name Firmagon for degarelix for injection, a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of advanced prostate cancer."

Obviously 'Hardongone' ( great name for an anti-androgen ) was a little too obvious but they sneaked 'Firmagon' through FDA approval.

No comments:

Post a Comment